Click for best price
Recombinant Hamster Ovary Cell CHO Hepatitis B Vaccine Market Size, Share 2023
Hepatitis B is a viral infection caused due to transmission of the virus through contact with the blood or other body fluids of an infected person. It is considered as a serious occupational hazard for healthcare professionals, which affects the liver, causing acute and chronic diseases. Hence, Chinese hamster ovary cell (CHO) hepatitis B vaccine is considered to be the safe and effective method to prevent the hepatitis B infection. The major factor that fuels the growth of the market are increase in prevalence of hepatitis B infection worldwide. For example, approximately 887,000 deaths due to hepatitis B infection were recorded in 2015 across the globe. However, inherent disadvantages of using recombinant Chinese hamster ovary cell (CHO) to design hepatitis B vaccines restrains the growth of the market. Conversely, increase in government focus to promote (CHO) hepatitis B vaccination for adults and extensive research carried out for the same are expected to offer lucrative opportunities for the market.
This report aims to provide a comprehensive presentation of the global market for Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine. This report contains market size and forecasts of Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine in global, including the following market information:
Global Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Market Revenue, 2018-2023, 2024-2029, ($ millions)
Global Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Market Sales, 2018-2023, 2024-2029, (K Doses)
Global top five Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine companies in 2022 (%)
The global Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine market was valued at US$ million in 2022 and is projected to reach US$ million by 2029, at a CAGR of % during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
The U.S. Market is Estimated at $ Million in 2022, While China is Forecast to Reach $ Million.
Pediatric Hepatitis B (CHO) Vaccine Segment to Reach $ Million by 2029, with a % CAGR in next six years.
The global key manufacturers of Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine include Merck & Co., Inc., GlaxoSmithKline Plc, Pfizer Inc., Sanofi Pasteur, CSL Limited, Emergent Biosolutions, Serum Institute of India and Johnson & Johnson, etc. in 2022, the global top five players have a share approximately % in terms of revenue.
We surveyed the Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Market, by Type, 2018-2023, 2024-2029 ($ Millions) & (K Doses)
Global Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Market Segment Percentages, by Type, 2022 (%)
Pediatric Hepatitis B (CHO) Vaccine
Adult Hepatitis B (CHO) Vaccine
Global Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Market, by Application, 2018-2023, 2024-2029 ($ Millions) & (K Doses)
Global Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Market Segment Percentages, by Application, 2022 (%)
Hospitals
Clinics
Global Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Market, By Region and Country, 2018-2023, 2024-2029 ($ Millions) & (K Doses)
Global Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Market Segment Percentages, By Region and Country, 2022 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine revenues in global market, 2018-2023 (Estimated), ($ millions)
Key companies Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine revenues share in global market, 2022 (%)
Key companies Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine sales in global market, 2018-2023 (Estimated), (K Doses)
Key companies Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine sales share in global market, 2022 (%)
Further, the report presents profiles of competitors in the market, key players include:
Merck & Co., Inc.
GlaxoSmithKline Plc
Pfizer Inc.
Sanofi Pasteur
CSL Limited
Emergent Biosolutions
Serum Institute of India
Johnson & Johnson
Outline of Major Chapters:
Chapter 1: Introduces the definition of Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine, market overview.
Chapter 2: Global Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine market size in revenue and volume.
Chapter 3: Detailed analysis of Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: Global Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine capacity by region & country.
Chapter 9: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 10: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 11: The main points and conclusions of the report.
| Report Attributes |
Report Details |
| Report Title |
Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Market, Global Outlook and Forecast 2023-2029 |
| Historical Year |
2018 to 2022 (Data from 2010 can be provided as per availability) |
| Base Year |
2022 |
| Forecast Year |
2030 |
| Number of Pages |
73 Pages |
| Customization Available |
Yes, the report can be customized as per your need. |
TABLE OF CONTENTS
1 Introduction to Research & Analysis Reports
1.1 Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Overall Market Size
2.1 Global Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Market Size: 2022 VS 2029
2.2 Global Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Revenue, Prospects & Forecasts: 2018-2029
2.3 Global Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Sales: 2018-2029
3 Company Landscape
3.1 Top Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Players in Global Market
3.2 Top Global Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Companies Ranked by Revenue
3.3 Global Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Revenue by Companies
3.4 Global Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Sales by Companies
3.5 Global Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Price by Manufacturer (2018-2023)
3.6 Top 3 and Top 5 Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Companies in Global Market, by Revenue in 2022
3.7 Global Manufacturers Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Product Type
3.8 Tier 1, Tier 2 and Tier 3 Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Players in Global Market
3.8.1 List of Global Tier 1 Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Companies
3.8.2 List of Global Tier 2 and Tier 3 Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Companies
4 Sights by Product
4.1 Overview
4.1.1 By Type - Global Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Market Size Markets, 2022 & 2029
4.1.2 Pediatric Hepatitis B (CHO) Vaccine
4.1.3 Adult Hepatitis B (CHO) Vaccine
4.2 By Type - Global Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Revenue & Forecasts
4.2.1 By Type - Global Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Revenue, 2018-2023
4.2.2 By Type - Global Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Revenue, 2024-2029
4.2.3 By Type - Global Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Revenue Market Share, 2018-2029
4.3 By Type - Global Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Sales & Forecasts
4.3.1 By Type - Global Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Sales, 2018-2023
4.3.2 By Type - Global Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Sales, 2024-2029
4.3.3 By Type - Global Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Sales Market Share, 2018-2029
4.4 By Type - Global Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Price (Manufacturers Selling Prices), 2018-2029
5 Sights by Application
5.1 Overview
5.1.1 By Application - Global Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Market Size, 2022 & 2029
5.1.2 Hospitals
5.1.3 Clinics
5.2 By Application - Global Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Revenue & Forecasts
5.2.1 By Application - Global Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Revenue, 2018-2023
5.2.2 By Application - Global Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Revenue, 2024-2029
5.2.3 By Application - Global Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Revenue Market Share, 2018-2029
5.3 By Application - Global Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Sales & Forecasts
5.3.1 By Application - Global Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Sales, 2018-2023
5.3.2 By Application - Global Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Sales, 2024-2029
5.3.3 By Application - Global Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Sales Market Share, 2018-2029
5.4 By Application - Global Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Price (Manufacturers Selling Prices), 2018-2029
6 Sights by Region
6.1 By Region - Global Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Market Size, 2022 & 2029
6.2 By Region - Global Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Revenue & Forecasts
6.2.1 By Region - Global Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Revenue, 2018-2023
6.2.2 By Region - Global Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Revenue, 2024-2029
6.2.3 By Region - Global Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Revenue Market Share, 2018-2029
6.3 By Region - Global Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Sales & Forecasts
6.3.1 By Region - Global Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Sales, 2018-2023
6.3.2 By Region - Global Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Sales, 2024-2029
6.3.3 By Region - Global Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Sales Market Share, 2018-2029
6.4 North America
6.4.1 By Country - North America Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Revenue, 2018-2029
6.4.2 By Country - North America Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Sales, 2018-2029
6.4.3 US Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Market Size, 2018-2029
6.4.4 Canada Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Market Size, 2018-2029
6.4.5 Mexico Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Market Size, 2018-2029
6.5 Europe
6.5.1 By Country - Europe Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Revenue, 2018-2029
6.5.2 By Country - Europe Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Sales, 2018-2029
6.5.3 Germany Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Market Size, 2018-2029
6.5.4 France Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Market Size, 2018-2029
6.5.5 U.K. Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Market Size, 2018-2029
6.5.6 Italy Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Market Size, 2018-2029
6.5.7 Russia Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Market Size, 2018-2029
6.5.8 Nordic Countries Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Market Size, 2018-2029
6.5.9 Benelux Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Market Size, 2018-2029
6.6 Asia
6.6.1 By Region - Asia Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Revenue, 2018-2029
6.6.2 By Region - Asia Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Sales, 2018-2029
6.6.3 China Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Market Size, 2018-2029
6.6.4 Japan Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Market Size, 2018-2029
6.6.5 South Korea Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Market Size, 2018-2029
6.6.6 Southeast Asia Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Market Size, 2018-2029
6.6.7 India Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Market Size, 2018-2029
6.7 South America
6.7.1 By Country - South America Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Revenue, 2018-2029
6.7.2 By Country - South America Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Sales, 2018-2029
6.7.3 Brazil Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Market Size, 2018-2029
6.7.4 Argentina Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Market Size, 2018-2029
6.8 Middle East & Africa
6.8.1 By Country - Middle East & Africa Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Revenue, 2018-2029
6.8.2 By Country - Middle East & Africa Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Sales, 2018-2029
6.8.3 Turkey Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Market Size, 2018-2029
6.8.4 Israel Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Market Size, 2018-2029
6.8.5 Saudi Arabia Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Market Size, 2018-2029
6.8.6 UAE Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Market Size, 2018-2029
7 Manufacturers & Brands Profiles
7.1 Merck & Co., Inc.
7.1.1 Merck & Co., Inc. Company Summary
7.1.2 Merck & Co., Inc. Business Overview
7.1.3 Merck & Co., Inc. Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Major Product Offerings
7.1.4 Merck & Co., Inc. Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Sales and Revenue in Global (2018-2023)
7.1.5 Merck & Co., Inc. Key News & Latest Developments
7.2 GlaxoSmithKline Plc
7.2.1 GlaxoSmithKline Plc Company Summary
7.2.2 GlaxoSmithKline Plc Business Overview
7.2.3 GlaxoSmithKline Plc Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Major Product Offerings
7.2.4 GlaxoSmithKline Plc Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Sales and Revenue in Global (2018-2023)
7.2.5 GlaxoSmithKline Plc Key News & Latest Developments
7.3 Pfizer Inc.
7.3.1 Pfizer Inc. Company Summary
7.3.2 Pfizer Inc. Business Overview
7.3.3 Pfizer Inc. Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Major Product Offerings
7.3.4 Pfizer Inc. Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Sales and Revenue in Global (2018-2023)
7.3.5 Pfizer Inc. Key News & Latest Developments
7.4 Sanofi Pasteur
7.4.1 Sanofi Pasteur Company Summary
7.4.2 Sanofi Pasteur Business Overview
7.4.3 Sanofi Pasteur Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Major Product Offerings
7.4.4 Sanofi Pasteur Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Sales and Revenue in Global (2018-2023)
7.4.5 Sanofi Pasteur Key News & Latest Developments
7.5 CSL Limited
7.5.1 CSL Limited Company Summary
7.5.2 CSL Limited Business Overview
7.5.3 CSL Limited Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Major Product Offerings
7.5.4 CSL Limited Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Sales and Revenue in Global (2018-2023)
7.5.5 CSL Limited Key News & Latest Developments
7.6 Emergent Biosolutions
7.6.1 Emergent Biosolutions Company Summary
7.6.2 Emergent Biosolutions Business Overview
7.6.3 Emergent Biosolutions Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Major Product Offerings
7.6.4 Emergent Biosolutions Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Sales and Revenue in Global (2018-2023)
7.6.5 Emergent Biosolutions Key News & Latest Developments
7.7 Serum Institute of India
7.7.1 Serum Institute of India Company Summary
7.7.2 Serum Institute of India Business Overview
7.7.3 Serum Institute of India Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Major Product Offerings
7.7.4 Serum Institute of India Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Sales and Revenue in Global (2018-2023)
7.7.5 Serum Institute of India Key News & Latest Developments
7.8 Johnson & Johnson
7.8.1 Johnson & Johnson Company Summary
7.8.2 Johnson & Johnson Business Overview
7.8.3 Johnson & Johnson Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Major Product Offerings
7.8.4 Johnson & Johnson Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Sales and Revenue in Global (2018-2023)
7.8.5 Johnson & Johnson Key News & Latest Developments
8 Global Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Production Capacity, Analysis
8.1 Global Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Production Capacity, 2018-2029
8.2 Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Production Capacity of Key Manufacturers in Global Market
8.3 Global Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Production by Region
9 Key Market Trends, Opportunity, Drivers and Restraints
9.1 Market Opportunities & Trends
9.2 Market Drivers
9.3 Market Restraints
10 Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Supply Chain Analysis
10.1 Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Industry Value Chain
10.2 Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Upstream Market
10.3 Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Downstream and Clients
10.4 Marketing Channels Analysis
10.4.1 Marketing Channels
10.4.2 Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Distributors and Sales Agents in Global
11 Conclusion
12 Appendix
12.1 Note
12.2 Examples of Clients
12.3 Disclaimer
LIST OF TABLES & FIGURES
List of Tables
Table 1. Key Players of Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine in Global Market
Table 2. Top Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Players in Global Market, Ranking by Revenue (2022)
Table 3. Global Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Revenue by Companies, (US$, Mn), 2018-2023
Table 4. Global Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Revenue Share by Companies, 2018-2023
Table 5. Global Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Sales by Companies, (K Doses), 2018-2023
Table 6. Global Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Sales Share by Companies, 2018-2023
Table 7. Key Manufacturers Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Price (2018-2023) & (USD/Dose)
Table 8. Global Manufacturers Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Product Type
Table 9. List of Global Tier 1 Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 11. By Type ? Global Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Revenue, (US$, Mn), 2022 & 2029
Table 12. By Type - Global Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Revenue (US$, Mn), 2018-2023
Table 13. By Type - Global Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Revenue (US$, Mn), 2024-2029
Table 14. By Type - Global Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Sales (K Doses), 2018-2023
Table 15. By Type - Global Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Sales (K Doses), 2024-2029
Table 16. By Application ? Global Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Revenue, (US$, Mn), 2022 & 2029
Table 17. By Application - Global Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Revenue (US$, Mn), 2018-2023
Table 18. By Application - Global Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Revenue (US$, Mn), 2024-2029
Table 19. By Application - Global Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Sales (K Doses), 2018-2023
Table 20. By Application - Global Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Sales (K Doses), 2024-2029
Table 21. By Region ? Global Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Revenue, (US$, Mn), 2022 VS 2029
Table 22. By Region - Global Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Revenue (US$, Mn), 2018-2023
Table 23. By Region - Global Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Revenue (US$, Mn), 2024-2029
Table 24. By Region - Global Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Sales (K Doses), 2018-2023
Table 25. By Region - Global Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Sales (K Doses), 2024-2029
Table 26. By Country - North America Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Revenue, (US$, Mn), 2018-2023
Table 27. By Country - North America Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Revenue, (US$, Mn), 2024-2029
Table 28. By Country - North America Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Sales, (K Doses), 2018-2023
Table 29. By Country - North America Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Sales, (K Doses), 2024-2029
Table 30. By Country - Europe Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Revenue, (US$, Mn), 2018-2023
Table 31. By Country - Europe Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Revenue, (US$, Mn), 2024-2029
Table 32. By Country - Europe Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Sales, (K Doses), 2018-2023
Table 33. By Country - Europe Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Sales, (K Doses), 2024-2029
Table 34. By Region - Asia Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Revenue, (US$, Mn), 2018-2023
Table 35. By Region - Asia Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Revenue, (US$, Mn), 2024-2029
Table 36. By Region - Asia Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Sales, (K Doses), 2018-2023
Table 37. By Region - Asia Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Sales, (K Doses), 2024-2029
Table 38. By Country - South America Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Revenue, (US$, Mn), 2018-2023
Table 39. By Country - South America Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Revenue, (US$, Mn), 2024-2029
Table 40. By Country - South America Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Sales, (K Doses), 2018-2023
Table 41. By Country - South America Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Sales, (K Doses), 2024-2029
Table 42. By Country - Middle East & Africa Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Revenue, (US$, Mn), 2018-2023
Table 43. By Country - Middle East & Africa Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Revenue, (US$, Mn), 2024-2029
Table 44. By Country - Middle East & Africa Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Sales, (K Doses), 2018-2023
Table 45. By Country - Middle East & Africa Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Sales, (K Doses), 2024-2029
Table 46. Merck & Co., Inc. Company Summary
Table 47. Merck & Co., Inc. Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Product Offerings
Table 48. Merck & Co., Inc. Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Sales (K Doses), Revenue (US$, Mn) and Average Price (USD/Dose) (2018-2023)
Table 49. Merck & Co., Inc. Key News & Latest Developments
Table 50. GlaxoSmithKline Plc Company Summary
Table 51. GlaxoSmithKline Plc Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Product Offerings
Table 52. GlaxoSmithKline Plc Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Sales (K Doses), Revenue (US$, Mn) and Average Price (USD/Dose) (2018-2023)
Table 53. GlaxoSmithKline Plc Key News & Latest Developments
Table 54. Pfizer Inc. Company Summary
Table 55. Pfizer Inc. Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Product Offerings
Table 56. Pfizer Inc. Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Sales (K Doses), Revenue (US$, Mn) and Average Price (USD/Dose) (2018-2023)
Table 57. Pfizer Inc. Key News & Latest Developments
Table 58. Sanofi Pasteur Company Summary
Table 59. Sanofi Pasteur Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Product Offerings
Table 60. Sanofi Pasteur Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Sales (K Doses), Revenue (US$, Mn) and Average Price (USD/Dose) (2018-2023)
Table 61. Sanofi Pasteur Key News & Latest Developments
Table 62. CSL Limited Company Summary
Table 63. CSL Limited Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Product Offerings
Table 64. CSL Limited Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Sales (K Doses), Revenue (US$, Mn) and Average Price (USD/Dose) (2018-2023)
Table 65. CSL Limited Key News & Latest Developments
Table 66. Emergent Biosolutions Company Summary
Table 67. Emergent Biosolutions Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Product Offerings
Table 68. Emergent Biosolutions Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Sales (K Doses), Revenue (US$, Mn) and Average Price (USD/Dose) (2018-2023)
Table 69. Emergent Biosolutions Key News & Latest Developments
Table 70. Serum Institute of India Company Summary
Table 71. Serum Institute of India Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Product Offerings
Table 72. Serum Institute of India Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Sales (K Doses), Revenue (US$, Mn) and Average Price (USD/Dose) (2018-2023)
Table 73. Serum Institute of India Key News & Latest Developments
Table 74. Johnson & Johnson Company Summary
Table 75. Johnson & Johnson Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Product Offerings
Table 76. Johnson & Johnson Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Sales (K Doses), Revenue (US$, Mn) and Average Price (USD/Dose) (2018-2023)
Table 77. Johnson & Johnson Key News & Latest Developments
Table 78. Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Production Capacity (K Doses) of Key Manufacturers in Global Market, 2021-2023 (K Doses)
Table 79. Global Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Capacity Market Share of Key Manufacturers, 2021-2023
Table 80. Global Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Production by Region, 2018-2023 (K Doses)
Table 81. Global Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Production by Region, 2024-2029 (K Doses)
Table 82. Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Market Opportunities & Trends in Global Market
Table 83. Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Market Drivers in Global Market
Table 84. Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Market Restraints in Global Market
Table 85. Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Raw Materials
Table 86. Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Raw Materials Suppliers in Global Market
Table 87. Typical Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Downstream
Table 88. Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Downstream Clients in Global Market
Table 89. Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Distributors and Sales Agents in Global Market
List of Figures
Figure 1. Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Segment by Type in 2022
Figure 2. Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Segment by Application in 2022
Figure 3. Global Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Market Overview: 2022
Figure 4. Key Caveats
Figure 5. Global Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Market Size: 2022 VS 2029 (US$, Mn)
Figure 6. Global Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Revenue, 2018-2029 (US$, Mn)
Figure 7. Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Sales in Global Market: 2018-2029 (K Doses)
Figure 8. The Top 3 and 5 Players Market Share by Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Revenue in 2022
Figure 9. By Type - Global Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Revenue, (US$, Mn), 2022 & 2029
Figure 10. By Type - Global Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Revenue Market Share, 2018-2029
Figure 11. By Type - Global Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Sales Market Share, 2018-2029
Figure 12. By Type - Global Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Price (USD/Dose), 2018-2029
Figure 13. By Application - Global Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Revenue, (US$, Mn), 2022 & 2029
Figure 14. By Application - Global Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Revenue Market Share, 2018-2029
Figure 15. By Application - Global Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Sales Market Share, 2018-2029
Figure 16. By Application - Global Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Price (USD/Dose), 2018-2029
Figure 17. By Region - Global Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Revenue, (US$, Mn), 2022 & 2029
Figure 18. By Region - Global Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Revenue Market Share, 2018 VS 2022 VS 2029
Figure 19. By Region - Global Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Revenue Market Share, 2018-2029
Figure 20. By Region - Global Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Sales Market Share, 2018-2029
Figure 21. By Country - North America Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Revenue Market Share, 2018-2029
Figure 22. By Country - North America Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Sales Market Share, 2018-2029
Figure 23. US Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Revenue, (US$, Mn), 2018-2029
Figure 24. Canada Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Revenue, (US$, Mn), 2018-2029
Figure 25. Mexico Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Revenue, (US$, Mn), 2018-2029
Figure 26. By Country - Europe Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Revenue Market Share, 2018-2029
Figure 27. By Country - Europe Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Sales Market Share, 2018-2029
Figure 28. Germany Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Revenue, (US$, Mn), 2018-2029
Figure 29. France Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Revenue, (US$, Mn), 2018-2029
Figure 30. U.K. Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Revenue, (US$, Mn), 2018-2029
Figure 31. Italy Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Revenue, (US$, Mn), 2018-2029
Figure 32. Russia Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Revenue, (US$, Mn), 2018-2029
Figure 33. Nordic Countries Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Revenue, (US$, Mn), 2018-2029
Figure 34. Benelux Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Revenue, (US$, Mn), 2018-2029
Figure 35. By Region - Asia Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Revenue Market Share, 2018-2029
Figure 36. By Region - Asia Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Sales Market Share, 2018-2029
Figure 37. China Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Revenue, (US$, Mn), 2018-2029
Figure 38. Japan Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Revenue, (US$, Mn), 2018-2029
Figure 39. South Korea Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Revenue, (US$, Mn), 2018-2029
Figure 40. Southeast Asia Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Revenue, (US$, Mn), 2018-2029
Figure 41. India Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Revenue, (US$, Mn), 2018-2029
Figure 42. By Country - South America Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Revenue Market Share, 2018-2029
Figure 43. By Country - South America Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Sales Market Share, 2018-2029
Figure 44. Brazil Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Revenue, (US$, Mn), 2018-2029
Figure 45. Argentina Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Revenue, (US$, Mn), 2018-2029
Figure 46. By Country - Middle East & Africa Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Revenue Market Share, 2018-2029
Figure 47. By Country - Middle East & Africa Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Sales Market Share, 2018-2029
Figure 48. Turkey Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Revenue, (US$, Mn), 2018-2029
Figure 49. Israel Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Revenue, (US$, Mn), 2018-2029
Figure 50. Saudi Arabia Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Revenue, (US$, Mn), 2018-2029
Figure 51. UAE Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Revenue, (US$, Mn), 2018-2029
Figure 52. Global Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Production Capacity (K Doses), 2018-2029
Figure 53. The Percentage of Production Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine by Region, 2022 VS 2029
Figure 54. Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Industry Value Chain
Figure 55. Marketing Channels
